Christopher Bunka, CEO, 10% Owner at Lexaria Bioscience Corp. (LXRP), bought 7,500 shares at $0.12 ($964) on 2016-07-22, disclosed to the SEC on 2016-07-22.
Open-market purchase of $964 LXRP by CEO, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.12 | 1,100 | $132 | 13.7% |
| 2 | $0.13 | 6,400 | $832 | 86.3% |
| Total | $0.13 avg | 7,500 | $964 | 100% |
| Filing → |
| LXRP | BUY | 2016-10-11 | $3K | — | Filing → |
| LXRP | BUY | 2016-10-06 | $375 | — | Filing → |
| LXRP | BUY | 2016-08-29 | $663 | — | Filing → |